RBF Capital’s Nuvation Bio NUVB Stock Holding History

RBF Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$172K	Hold	40,000	–	–	0.01%	467
2025 Q4	$358K	Hold	40,000	–	–	0.02%	452
2025 Q3	$148K	Hold	40,000	–	–	0.01%	543
2025 Q2	$78K	Sell	40,000 -61,561	-61%	-$128K	﹤0.01%	587
2025 Q1	$179K	Hold	101,561	–	–	0.01%	523
2024 Q4	$286K	Sell	101,561 -55,114	-35%	-$142K	0.01%	468
2024 Q3	$398K	Hold	156,675	–	–	0.02%	455
2024 Q2	$457K	Hold	156,675	–	–	0.03%	404
2024 Q1	$570K	Sell	156,675 -5,582	-3%	-$10.7K	0.03%	380
2023 Q4	$245K	Hold	162,257	–	–	0.01%	472
2023 Q3	$217K	Sell	162,257 -15,503	-9%	-$25.8K	0.01%	459
2023 Q2	$322K	Hold	177,760	–	–	0.02%	417
2023 Q1	$294K	Hold	177,760	–	–	0.02%	406
2022 Q4	$339K	Buy	+177,760	New	+$360K	0.03%	393

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RBF Capital's NUVB Position: Q1 2026 in Review

RBF Capital held its Nuvation Bio (NUVB) position steady in Q1 2026 at 40,000 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #467.

RBF Capital first reported a position in NUVB in Q4 2022 and has held it in 14 quarters since. The position peaked at $570K in Q1 2024. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

RBF Capital held 40,000 shares of Nuvation Bio worth $172K as of Q1 2026.
RBF Capital left its Nuvation Bio share count unchanged in Q1 2026.
Nuvation Bio made up 0.01% of RBF Capital's portfolio in Q1 2026, its #467 holding.
RBF Capital first reported a position in Nuvation Bio in Q4 2022 and has held it in 14 quarters since.
RBF Capital's Nuvation Bio position peaked at $570K in Q1 2024.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.